224 related articles for article (PubMed ID: 20092987)
1. Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells.
Yue QX; Song XY; Ma C; Feng LX; Guan SH; Wu WY; Yang M; Jiang BH; Liu X; Cui YJ; Guo DA
Phytomedicine; 2010 Jul; 17(8-9):606-13. PubMed ID: 20092987
[TBL] [Abstract][Full Text] [Related]
2. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3.
Hsieh TC; Wu JM
Int J Mol Med; 2011 Dec; 28(6):1065-9. PubMed ID: 21887458
[TBL] [Abstract][Full Text] [Related]
3. Ganoderic acid Mf and S induce mitochondria mediated apoptosis in human cervical carcinoma HeLa cells.
Liu RM; Zhong JJ
Phytomedicine; 2011 Mar; 18(5):349-55. PubMed ID: 21036023
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of 9,11-dehydroergosterol peroxide isolated from Ganoderma lucidum and its target-related proteins.
Cui YJ; Guan SH; Feng LX; Song XY; Ma C; Cheng CR; Wang WB; Wu WY; Yue QX; Liu X; Guo DA
Nat Prod Commun; 2010 Aug; 5(8):1183-6. PubMed ID: 20839614
[TBL] [Abstract][Full Text] [Related]
5. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network.
Yue QX; Cao ZW; Guan SH; Liu XH; Tao L; Wu WY; Li YX; Yang PY; Liu X; Guo DA
Mol Cell Proteomics; 2008 May; 7(5):949-61. PubMed ID: 18166740
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and pro-apoptotic effects of novel ganoderic acid derivatives on human cervical cancer cells in vitro.
Liu RM; Li YB; Zhong JJ
Eur J Pharmacol; 2012 Apr; 681(1-3):23-33. PubMed ID: 22366428
[TBL] [Abstract][Full Text] [Related]
7. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells.
Tang W; Liu JW; Zhao WM; Wei DZ; Zhong JJ
Life Sci; 2006 Dec; 80(3):205-11. PubMed ID: 17007887
[TBL] [Abstract][Full Text] [Related]
8. Ganoderic acid produced from submerged culture of Ganoderma lucidum induces cell cycle arrest and cytotoxicity in human hepatoma cell line BEL7402.
Yang HL
Biotechnol Lett; 2005 Jun; 27(12):835-8. PubMed ID: 16086244
[TBL] [Abstract][Full Text] [Related]
9. Regulation of osteoclastogenesis by ganoderic acid DM isolated from Ganoderma lucidum.
Miyamoto I; Liu J; Shimizu K; Sato M; Kukita A; Kukita T; Kondo R
Eur J Pharmacol; 2009 Jan; 602(1):1-7. PubMed ID: 19026632
[TBL] [Abstract][Full Text] [Related]
10. Extraction optimisation and isolation of triterpenoids from Ganoderma lucidum and their effect on human carcinoma cell growth.
Ruan W; Lim AH; Huang LG; Popovich DG
Nat Prod Res; 2014; 28(24):2264-72. PubMed ID: 25032738
[TBL] [Abstract][Full Text] [Related]
11. [Simultaneous HPLC determination of four triterpenoid acids in Ganoderma lucidum].
Zhao J; Chen X; Bi K
Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(17):2220-2. PubMed ID: 19943490
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and anti-tumor-promoting effects of triterpene acids and sterols from the fungus Ganoderma lucidum.
Akihisa T; Nakamura Y; Tagata M; Tokuda H; Yasukawa K; Uchiyama E; Suzuki T; Kimura Y
Chem Biodivers; 2007 Feb; 4(2):224-31. PubMed ID: 17311233
[TBL] [Abstract][Full Text] [Related]
13. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum.
Li YQ; Wang SF
Biotechnol Lett; 2006 Jun; 28(11):837-41. PubMed ID: 16786250
[TBL] [Abstract][Full Text] [Related]
14. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity.
Seo HW; Hung TM; Na M; Jung HJ; Kim JC; Choi JS; Kim JH; Lee HK; Lee I; Bae K; Hattori M; Min BS
Arch Pharm Res; 2009 Nov; 32(11):1573-9. PubMed ID: 20091270
[TBL] [Abstract][Full Text] [Related]
15. Separation and determination of four ganoderic acids from dried fermentation mycelia powder of Ganoderma lucidum by capillary zone electrophoresis.
Ding N; Yang Q; Huang SS; Fan LY; Zhang W; Zhong JJ; Cao CX
J Pharm Biomed Anal; 2010 Dec; 53(5):1224-30. PubMed ID: 20719456
[TBL] [Abstract][Full Text] [Related]
16. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells.
Min BS; Gao JJ; Nakamura N; Hattori M
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):1026-33. PubMed ID: 10923835
[TBL] [Abstract][Full Text] [Related]
17. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
Liu J; Shiono J; Shimizu K; Kukita A; Kukita T; Kondo R
Bioorg Med Chem Lett; 2009 Apr; 19(8):2154-7. PubMed ID: 19289282
[TBL] [Abstract][Full Text] [Related]
18. Enhanced production of ganoderic acids and cytotoxicity of Ganoderma lucidum using solid-medium culture.
You BJ; Lee HZ; Chung KR; Lee MH; Huang MJ; Tien N; Chan CW; Kuo YH
Biosci Biotechnol Biochem; 2012; 76(8):1529-34. PubMed ID: 22878212
[TBL] [Abstract][Full Text] [Related]
19. Distinct Responses of Cytotoxic Ganoderma lucidum Triterpenoids in Human Carcinoma Cells.
Ruan W; Wei Y; Popovich DG
Phytother Res; 2015 Nov; 29(11):1744-52. PubMed ID: 26292672
[TBL] [Abstract][Full Text] [Related]
20. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum.
Fatmawati S; Shimizu K; Kondo R
Fitoterapia; 2010 Dec; 81(8):1033-6. PubMed ID: 20603199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
